Eaton Vance Management grew its holdings in shares of IBM (NYSE:IBM) by 4.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 736,079 shares of the technology company’s stock after buying an additional 31,213 shares during the period. Eaton Vance Management owned approximately 0.08% of IBM worth $112,929,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of the business. Allen Capital Group LLC bought a new position in shares of IBM during the 4th quarter worth approximately $424,000. Capital Analysts LLC boosted its holdings in shares of IBM by 100.5% during the 4th quarter. Capital Analysts LLC now owns 1,129 shares of the technology company’s stock worth $125,000 after buying an additional 566 shares in the last quarter. Day & Ennis LLC boosted its holdings in shares of IBM by 6.8% during the 4th quarter. Day & Ennis LLC now owns 7,217 shares of the technology company’s stock worth $1,107,000 after buying an additional 461 shares in the last quarter. Standard Life Aberdeen plc boosted its holdings in shares of IBM by 1.6% during the 4th quarter. Standard Life Aberdeen plc now owns 558,457 shares of the technology company’s stock worth $85,732,000 after buying an additional 8,556 shares in the last quarter. Finally, Estabrook Capital Management boosted its holdings in shares of IBM by 26.1% during the 4th quarter. Estabrook Capital Management now owns 82,322 shares of the technology company’s stock worth $12,630,000 after buying an additional 17,045 shares in the last quarter. Hedge funds and other institutional investors own 57.02% of the company’s stock.
A number of brokerages have recently weighed in on IBM. Zacks Investment Research lowered IBM from a “hold” rating to a “sell” rating in a research report on Tuesday, December 19th. Societe Generale set a $149.00 target price on IBM and gave the stock a “sell” rating in a research report on Friday, January 19th. Cantor Fitzgerald reaffirmed a “hold” rating and set a $152.00 target price on shares of IBM in a research report on Friday, January 19th. Morgan Stanley upped their target price on IBM to $198.00 and gave the stock an “overweight” rating in a research report on Friday, January 19th. Finally, Royal Bank of Canada raised IBM from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $160.00 to $180.00 in a research report on Wednesday, January 3rd. They noted that the move was a valuation call. Seven analysts have rated the stock with a sell rating, sixteen have given a hold rating and eleven have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $166.01.
NYSE IBM opened at $156.71 on Monday. The firm has a market capitalization of $145,609.02, a P/E ratio of 11.36, a P/E/G ratio of 2.31 and a beta of 0.90. IBM has a 12 month low of $139.13 and a 12 month high of $171.69. The company has a quick ratio of 1.29, a current ratio of 1.33 and a debt-to-equity ratio of 2.25.
IBM (NYSE:IBM) last released its quarterly earnings results on Thursday, January 18th. The technology company reported $5.18 EPS for the quarter, beating analysts’ consensus estimates of $5.17 by $0.01. The business had revenue of $22.54 billion during the quarter, compared to analyst estimates of $22.03 billion. IBM had a return on equity of 69.48% and a net margin of 7.27%. IBM’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.01 EPS. equities analysts expect that IBM will post 13.83 EPS for the current year.
International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers.
Want to see what other hedge funds are holding IBM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IBM (NYSE:IBM).
Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.